We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+3.38%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$43.8B
AUM Growth
-$4B
(-8.4%)
Cap. Flow
-$2.6B
Cap. Flow
% of AUM
-5.95%
Top 10 Holdings %
Top 10 Hldgs %
10.61%
Holding
2,617
New
198
Increased
927
Reduced
931
Closed
480
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$168M |
| 2 |
AbbVie
ABBV
|
+$164M |
| 3 |
TSMC
TSM
|
+$147M |
| 4 |
Amgen
AMGN
|
+$139M |
| 5 |
Walmart Inc
WMT
|
+$121M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$186M |
| 2 |
AGN
Allergan Inc
AGN
|
+$175M |
| 3 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$175M |
| 4 |
HCBK
HUDSON CITY BANCORP INC
HCBK
|
+$172M |
| 5 |
TQNT
TRIQUINT SEMICONDUCTOR INC
TQNT
|
+$164M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.89% |
| 2 | Technology | 16.32% |
| 3 | Financials | 12.49% |
| 4 | Consumer Discretionary | 10.57% |
| 5 | Industrials | 10.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
Builders FirstSource
BLDR
$8.04B
| $78K | ﹤0.01% |
11,700
| – | – |
|
2102
Stereotaxis
STXS
$141M
| $78K | ﹤0.01% |
47,500
-11,875
| -20% | -$18.9K |
|
2103
RF Industries
RFIL
$139M
| $77K | ﹤0.01% |
18,713
-400
| -2% | -$1.7K |
|
2104
TherapeuticsMD
TXMD
$24M
| $75K | ﹤0.01% |
248
-2,022
| -89% | -$494K |
|
2105
Coeur Mining
CDE
$17.9B
| $73K | ﹤0.01% |
15,427
-32,330
| -68% | -$188K |
|
2106
Oxford Square Capital
OXSQ
$157M
| $70K | ﹤0.01% |
10,159
-15,100
| -60% | -$111K |
|
2107
Urban One Class D
UONEK
$23.8M
| $68K | ﹤0.01% |
2,220
-750
| -25% | -$17.5K |
|
2108
Palisade Bio
PALI
$367M
| – | – |
0
| – | – |
|
|
ENZ
2109
DELISTED
Enzo Biochem, Inc.
ENZ
| $67K | ﹤0.01% |
22,700
-21,800
| -49% | -$71.4K |
|
|
ZIXI
2110
DELISTED
Zix Corporation
ZIXI
| $65K | ﹤0.01% |
16,500
-5,600
| -25% | -$21.2K |
|
|
BIOL
2111
DELISTED
Biolase, Inc.
BIOL
| $63K | ﹤0.01% |
2
-1
| -33% | -$28.3K |
|
2112
Digital Turbine
APPS
$1.74B
| $62K | ﹤0.01% |
18,900
-4,300
| -19% | -$14.6K |
|
2113
NanoViricides
NNVC
$36.2M
| $62K | ﹤0.01% |
1,370
-1,065
| -44% | -$56.8K |
|
2114
eGain
EGAN
$201M
| $58K | ﹤0.01% |
17,677
-1,500
| -8% | -$6.08K |
|
|
RVLT
2115
DELISTED
Revolution Lighting Technologies, Inc. - Class A
RVLT
| $58K | ﹤0.01% |
5,184
-2,570
| -33% | -$29.8K |
|
2116
Aemetis
AMTX
$124M
| $57K | ﹤0.01% |
13,400
-2,200
| -14% | -$9.53K |
|
|
RBCN
2117
DELISTED
Rubicon Technology, Inc.
RBCN
| $55K | ﹤0.01% |
+1,400
| New | +$59.6K |
|
|
WILN
2118
DELISTED
Wi-LAN Inc.
WILN
| $53K | ﹤0.01% |
+21,600
| New | +$59.5K |
|
2119
IAMGOLD
IAG
$10.5B
| $50K | ﹤0.01% |
26,600
-538,800
| -95% | -$1.33M |
|
|
FLNA
2120
Filana Therapeutics
FLNA
$48.1M
| $47K | ﹤0.01% |
3,571
-586
| -14% | -$7.91K |
|
|
NAVB
2121
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
| $46K | ﹤0.01% |
1,455
| – | – |
|
|
CBR
2122
DELISTED
CIBER Inc.
CBR
| $42K | ﹤0.01% |
10,100
| – | – |
|
2123
Energy Recovery
ERII
$443M
| $38K | ﹤0.01% |
14,800
-4,600
| -24% | -$15.8K |
|
2124
Mitek Systems
MITK
$834M
| $36K | ﹤0.01% |
11,503
-12,300
| -52% | -$39.3K |
|
|
NBSE
2125
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| $33K | ﹤0.01% |
33
| – | – |
|
Similar funds
VGA
AQR Capital Management's Q1 2015 Portfolio in Review
As of Q1 2015, AQR Capital Management held 2,617 positions worth $43.8B, down 8.4% from $47.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
AQR Capital Management withdrew a net $2.6B in Q1 2015, closing 480 positions and reducing 931 holdings. Its most notable exit was Allergan Inc, an estimated $175M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
Against the trend, AQR Capital Management opened a new position in Qorvo worth $68.6M.
- AQR Capital Management's largest Q1 2015 buy was Qorvo: 860,877 shares worth $68.6M.
- AQR Capital Management added most to Microsoft in Q1 2015, an estimated $168M increase.
- AQR Capital Management's biggest Q1 2015 reduction was TIME WARNER CABLE INC NEW COM STK, cutting an estimated $186M.
- AQR Capital Management fully exited Allergan Inc in Q1 2015, selling an estimated $175M.
- AQR Capital Management's ten largest holdings make up 11% of its $43.8B portfolio in Q1 2015.
- AQR Capital Management opened 198 new positions and closed 480 in Q1 2015.
- AQR Capital Management's portfolio value fell 8.4% quarter-over-quarter to $43.8B.
Based on AQR Capital Management's 13F filing for Q1 2015, filed 15 May 2015.